DIRS.INFO The most relevant business & tech news

☆ What all the cool kids want. How 6 portfolio stocks fared in Piper Sandler's new survey of teen likes and dislikes
▼ + stars: | 2024-04-09 | by ( Zev Fima | ) www.cnbc.com time to read: +8 min

Piper Sandler has released the spring edition of its semiannual "Taking Stock With Teens Survey," with solid results for several names in our portfolio. They added, that in their view, the Starbucks brand remains a "relevant social currency among teens." But they noted that Nike is now "starting to see weakness in overall brand mindshare." As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Piper Sandler, it's, Estee Lauder, Locker —, Instagram, TikTok, China's ByteDance, Dunkin, Locker, Foot, Jim Cramer's, Jim Cramer, Jim, Avishek Das Organizations: Teens Survey, Apple, Facebook, Apple Watch, Starbucks, MAC, Sporting Goods, Nike, Piper, CNBC, Getty Locations: Piper's, Israel, Asia

☆ Top banking analysts see 3 reasons why Wells Fargo stock should push even higher this year
▼ + stars: | 2024-03-13 | by ( Morgan Chittum | ) www.cnbc.com time to read: +7 min

Wells Fargo 's run of form continued Wednesday, with shares hitting another 52-week high. Wall Street analysts see more upside ahead for what's been the best-performing major U.S. bank stock in 2024. Shares of Wells Fargo have surged nearly 18% year-to-date, compared to the S & P 500 's 8.5% advance over the same stretch. Higher for longer Both analysts said a higher-for-longer interest rate environment creates a favorable setup for a money center bank like Wells Fargo. As the expectations for Fed cuts this year have been coming down, Wells Fargo stock has been climbing.

Persons: Wells, what's, Goldman Sachs, Morgan Stanley —, —, RBC Capital Market's Gerard Cassidy, Piper Sandler's Scott Siefers, Jim Cramer, RBC's Cassidy, Cash, Cassidy, Piper's Siefers, Siefers, Charlie Scharf, Scharf, that's, Jerome Powell, Jim Cramer's, Jim, Justin Sullivan Organizations: Wall, Peers, JPMorgan, Wells, CNBC, RBC Capital, Federal Reserve, Wells Fargo, Capital, Getty Locations: Wells Fargo, Wells, Basel

☆ Walmart's annuity business will lead into better valuations, says Piper's Ed Yruma
▼ + stars: | 2024-02-16 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWalmart's annuity business will lead into better valuations, says Piper's Ed YrumaEd Yruma, Piper Sandler managing director, joins 'Closing Bell' to discuss his high price target on Walmart as the company is set to report next week.

Persons: Ed Yruma Ed Yruma, Piper Sandler Organizations: Walmart

☆ Here are 7 portfolio stocks that can benefit from bigger tech budgets in the age of AI
▼ + stars: | 2023-12-12 | by ( Zev Fima | ) www.cnbc.com time to read: +6 min

In aggregate, the survey results point to a 60 to 70 basis point acceleration for IT spending growth in each of the next three years, with cloud spending growth much stronger at 150 to 300 basis points. Cloud and AI A rebound in cloud growth is expected thanks in large part the renewed focus and need to invest in artificial intelligence. In fact, 73% of the CIO respondents said they are "implementing now, plan to implement, or are testing generative AI." As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Piper Sandler's, Piper, OpenAI, Einstein, Jim Cramer, Jim Cramer's, Jim, Chino Organizations: Microsoft, Web Services, Google, IBM, Oracle, Nvidia, Piper, Broadcom, Marvell Technology, VMWare, Cybersecurity, Palo Alto Networks, Broadcom —, CNBC Locations: Silicon Valley, America

☆ Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end
▼ + stars: | 2023-10-29 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +11 min

Novo Nordisk and Eli Lilly reign over the anti-obesity drug market, and don't expect this duopoly to end soon, analysts say. All this goes on amid robust demand for Novo's semaglutide, which is sold as Ozempic for type 2 diabetes and as Wegovy for weight loss, and Lilly's tirzepatide, which hopes to receive regulatory approval for weight loss this year. Orforglipron is an oral drug Eli Lilly is developing. It has several other compounds in the pipeline, but Suvannavejh expects the weight loss drug to receive increased attention. "This range would also be competitive with LLY's orforglipron [an oral GLP-1 drug] weight loss at day 28," Smith said.

Persons: Eli Lilly, Piper Sandler, Yasmeen Rahimi, Cantor Fitzgerald, Louise Chen, Lilly, Lilly's, Chen, Price, Kyle Rasbach, We've, Rasbach, Altimmune Altimmune, NASH, Piper's, Rahimi, Cantor's Chen, it's, Eli Lilly's Mounjaro, Goldman Sachs, Chris Shibutani, David Risinger, Risinger, Jonathan Wolleben, Wolleben, Orforglipron, Graig Suvannavejh, Suvannavejh, Thomas Smith, LLY's, Smith, Yale Jen, Jen Organizations: Novo Nordisk, Pfizer, Novo, pharma, Pfizer Pfizer, danuglipron, Therapeutics, Leerink, Mizuho Securities, Viking Therapeutics Viking Therapeutics, Laidlaw & Co Locations: Novo, GLP, Eventide

☆ Wall Street hits Salesforce with a downgrade. Here's why Cramer disagrees
▼ + stars: | 2023-10-23 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +4 min

Enterprise software giant Salesforce (CRM) has been trudging through a challenged stretch of trading lately — but it's certainly no justification for a Wall Street downgrade, Jim Cramer said Monday. Salesforce appears well-positioned on both sales growth and profitability, even if some on Wall Street question its ability to deliver a growth mix on par with its software peers. Alongside its fiscal 2024 second-quarter results in late August, Salesforce tweaked its full-year revenue guidance to a level slightly above Wall Street consensus estimates at the time, implying nearly 11% year-over-year growth. However, the firm said Club holding Microsoft (MSFT) is still its favorite large-cap software stock to own into year-end, citing AI catalysts. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: it's, Jim Cramer, Piper Sandler, Salesforce, Jim, Marc Benioff, Jim Cramer's Organizations: Enterprise, Club, Microsoft, CNBC, Bloomberg, Getty Locations: Salesforce, ASAN, San Francisco

☆ 4 tech giants have cemented their AI dominance. But there's even more room for growth
▼ + stars: | 2023-10-16 | by ( Paulina Likos | ) www.cnbc.com time to read: +6 min

Nearly all tech companies will integrate generative AI by the end of 2024. Respondents said they expected to use generative AI for customer support, content generation and productivity. Google Cloud Google Cloud was the third most likely cloud provider in Oppenheimer's survey to gain future AI spending share. Salesforce and AI Oppenheimer analysts said they see "durable tailwinds for customer support, content generation and code generation, which are considered priority use cases for Generative AI." We agree with this call and are in the camp that Salesforce's generative AI tools should help reaccelerate sales growth all while balancing increasing margins.

Persons: Oppenheimer's, Oppenheimer, Piper Sandler, Copilot, Piper, we've, Salesforce, Jim Cramer's, Jim Cramer, Jim, Dado Ruvic Organizations: Microsoft, Web Services, Google, Meta, AI, Adobe, CNBC Locations: OpenAI, Jasper

☆ Obesity drugs’ popularity put a dent in these stocks. Why analysts say they’re still worth buying
▼ + stars: | 2023-09-08 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +7 min

Industry analysts are insisting that new weight loss and diabetes drugs like Ozempic won't hurt the demand for insulin pumps and continuous glucose monitors, but most investors aren't buying it. The answer may depend on who you listen to and whether you see GLP-1 drugs as a help or a hinderance to the category. DXCM 3M mountain In the quarter to date, Dexcom shares are down nearly 19%. Dexcom shares are down more than 7% year to date. TNDM 3M mountain Tandem Diabetes shares have fallen significantly this year.

Persons: Ozempic, Danielle Antalffy, Eli Lilly's Mounjaro, hasn't, Dexcom, Piper Sandler, Matt O'Brien, O'Brien, Paresh Dandona, semaglutide, Travis Steed, Steed, — CNBC's Michael Bloom Organizations: UBS, Nordisk's, Novo, New, of Medicine, Tandem Diabetes, Tandem Diabetes Care, Diabetes, Jacobs School of Medicine, Biomedical Sciences, University of Buffalo, Novo Nordisk's, Bank of America Locations: CGMs

☆ Analysts are going gaga over Nvidia before its earnings next week
▼ + stars: | 2023-08-16 | by ( Samantha Subin | ) www.cnbc.com time to read: +3 min

Nearly three months after Nvidia shocked Wall Street with blowout earnings and forecast thanks to accelerating AI demand , analysts are still going crazy for the chipmaker. NVDA 3M mountain Nvidia shares over the last three months Curtis justified the run-up in shares this year, noting that more companies are allocating cloud capital expenditure budgets toward AI, and Nvidia shows no signs of a "clear competitor" in the field. Raymond James analyst Srini Pajjuri said that tight supply issues could limit the near-term upside for Nvidia but that the generative AI story remains intact. He also called the steep valuation justified given the Jensen Huang -led company's dominance in AI and machine learning. While Deutsche Bank's Ross Seymore anticipates another "stunning" report and more upside from AI, he retained his hold rating on Nvidia shares.

Persons: Blayne Curtis, Curtis, Piper, Harsh Kumar, Kumar, Raymond James, Srini Pajjuri, Jensen Huang, Pajjuri, Ross Seymore, — CNBC's Michael Bloom Organizations: Nvidia, Barclays, AMD, Deutsche Locations: China

☆ Punter lands 50,000 pounds windfall from 14-year-old bet on Tongue debut
▼ + stars: | 2023-06-01 | by ( ) www.reuters.com time to read: +1 min

June 1 (Reuters) - One lucky punter who believed 14 years ago that Josh Tongue would one day play for England and placed a cheeky bet will win 50,000 pounds ($63,000) when the fast bowler makes his international debut against Ireland on Thursday. Tim Piper had watched Tongue play when he was just an 11-year-old and placed a 100-pound bet at odds of 500-1 that he would play a test match for England in the future. "I've kept the bet slip in a cupboard all these years," Piper told BBC Sport. Tongue had, however, contemplated retirement during a 15-month shoulder-injury layoff from 2021-2022 before two operations and botox injections fixed the issue. ($1 = 0.7923 pounds)Reporting by Rohith Nair in Bengaluru; editing by Pritha SarkarOur Standards: The Thomson Reuters Trust Principles.

Persons: Josh, Tim Piper, I've, Piper, Phil, Shane Warne, James Anderson, Ollie Robinson, Rohith Nair, Pritha Sarkar Organizations: England, Ireland, BBC Sport, Lord's, Thomson Locations: Worcestershire, Bengaluru

SummarySummary Law Firms Naomi Moore joins from Akin Gump to head DLA Piper's APAC restructuring practiceMoore will split her time between the firm's Hong Kong and Sydney officesMay 2 (Reuters) - Law firm DLA Piper has hired a partner from U.S.-founded rival Akin Gump Strauss Hauer & Feld in Hong Kong to serve as its new restructuring practice leader for the Asia Pacific region, the firm said Tuesday. Naomi Moore, who has been on sabbatical since she left Akin Gump in January, will divide her time between DLA Piper’s Sydney and Hong Kong offices, the firm said in a statement. In Hong Kong, Moore joins Trinh Hoang, DLA Piper’s only other restructuring-focused partner in the office, who joined the firm from Linklaters in October last year. Linklaters added a restructuring head in Hong Kong from Allen & Overy in October. An Akin Gump spokesperson wished Moore well on her new role.

April 26 (Reuters) - With more and more lawyers at major law firms using fast-advancing generative artificial intelligence tools, legal AI startup Harvey said Wednesday that it raised $21 million in fresh investor cash. Sequoia Capital, which is leading the Series A fundraising round, said more than 15,000 law firms are on a waiting list to start using Harvey. The company says it builds custom large language models for law firms. Technology companies and investors have rushed to embrace large language model-based generative AI since Microsoft-backed OpenAI's ChatGPT debuted in November. Casetext in March released its AI legal assistant product, CoCounsel, which uses GPT-4 to speed up tasks like legal research, contract analysis and document review.

☆ We expect to see the S&P at 3,225, says Piper's Kantrowitz
▼ + stars: | 2023-01-05 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe expect to see the S&P at 3,225, says Piper's KantrowitzMichael Kantrowitz, Piper Sandler, joins 'Power Lunch' to discuss housing, orders, profits and employment, and what those indicators says about the strength of the economy and stocks.

☆ Shares of DraftKings could surge 40%, to more than $20, Piper Sandler says
▼ + stars: | 2022-11-18 | by ( Sarah Min | ) www.cnbc.com time to read: +1 min

Shares of DraftKings could surge 40% from their current level, according to Piper Sandler. Analyst Matt Farrell initiated research coverage of DraftKings with an overweight rating, saying it's time for investors to take another look at the online sports betting company. Because of those concerns, shares of DraftKings tumbled more than 45% this year. Still, Piper expects that DraftKings has a "clear and repeatable" path to profitability, as the company targets fourth quarter 2023 as a breakeven point, based on 2023 adjusted EBITDA estimates, according to the note. "Overall, we recommend investors own DraftKings for exposure to the rapidly growing online sports betting and iGaming markets," Farrell wrote.

Search resuls for: "Piper's"

14 mentions found